Abstract
The aim of this study was to assess suicidality in a non-clinical sample during the perinatal period and to report suicidality
rates in women with major or minor depressive episode (MmD), assessed with the SCID, during the perinatal period. Women (1,066) were recruited at the third month of pregnancy and followed until the 12th month postpartum (N = 500). Suicidality was assessed with the MOODS-SR and with item 10 of the EPDS at different time-points during the perinatal
period. The period prevalence of suicidality was 6.9% (95% CI: 6.0–7.8) during pregnancy and 4.3% (95% CI: 3.4–5.2) during
postpartum, assessed with the MOODS-SR, and was 12.0% (95% CI: 10.8–13.2) during pregnancy and 8.6% (95% CI: 7.4–9.8) during
the postpartum period, assessed with the EPDS. The prevalence of suicidality in women who had MmD during pregnancy was 26.4%
and 34.1%, assessed with the MOODS-SR and the EPDS, respectively, while it was 18.4% (MOODS-SR) and 30.6% (EPDS) during the
postpartum period. Clinicians should assess suicidality in women presenting with MmD during the whole perinatal period. Furthermore,
suicidality should be assessed in women with a previous history of psychiatric disorder that reported a lifetime suicidal
ideation.
rates in women with major or minor depressive episode (MmD), assessed with the SCID, during the perinatal period. Women (1,066) were recruited at the third month of pregnancy and followed until the 12th month postpartum (N = 500). Suicidality was assessed with the MOODS-SR and with item 10 of the EPDS at different time-points during the perinatal
period. The period prevalence of suicidality was 6.9% (95% CI: 6.0–7.8) during pregnancy and 4.3% (95% CI: 3.4–5.2) during
postpartum, assessed with the MOODS-SR, and was 12.0% (95% CI: 10.8–13.2) during pregnancy and 8.6% (95% CI: 7.4–9.8) during
the postpartum period, assessed with the EPDS. The prevalence of suicidality in women who had MmD during pregnancy was 26.4%
and 34.1%, assessed with the MOODS-SR and the EPDS, respectively, while it was 18.4% (MOODS-SR) and 30.6% (EPDS) during the
postpartum period. Clinicians should assess suicidality in women presenting with MmD during the whole perinatal period. Furthermore,
suicidality should be assessed in women with a previous history of psychiatric disorder that reported a lifetime suicidal
ideation.
- Content Type Journal Article
- Category Original Article
- Pages 1-9
- DOI 10.1007/s00737-011-0246-y
- Authors
- Mauro Mauri, Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, School of Medicine, University of Pisa, Via Roma 67, 56100 Pisa, Italy
- Annalisa Oppo, Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, School of Medicine, University of Pisa, Via Roma 67, 56100 Pisa, Italy
- Chiara Borri, Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, School of Medicine, University of Pisa, Via Roma 67, 56100 Pisa, Italy
- Susanna Banti, Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, School of Medicine, University of Pisa, Via Roma 67, 56100 Pisa, Italy
- for PND-ReScU group
- Journal Archives of Women’s Mental Health
- Online ISSN 1435-1102
- Print ISSN 1434-1816